Becker's Healthcare March 3, 2023
Giles Bruce

The FDA has rejected a request from Elon Musk’s Neuralink to test its brain chips on humans, according to a March 2 TechCrunch story.

The agency had concerns the implant’s “neural lace” could trek into the soft tissue of the brain, that the chip could overheat, the battery might fail, and that removal could damage the brain, the news outlet wrote, citing Reuters reporting.

“This technology in all its forms represents a potential breakthrough for people with debilitating...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Technology
Related Articles:
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know

Share This Article